Aastha Singh

Employment

• Van Andel Institute Postdoctoral fellow
  2025 - Present
• University of Helsinki Postdoctoral researcher
  2024 - 2025
• University of Helsinki Doctoral researcher
  2018 - 2024
• University of Helsinki

Education

• University of Helsinki

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Modulation of the unfolded protein response with a C-terminal fragment of MANF facilitates recovery in models of multiple sclerosis
  Molecular therapy 2026 DOI: 10.1016/j.ymthe.2025.10.023
  +Save
• Optimization of alpha-synuclein-based models of Parkinson's disease and effect of CDNF on neuronal damage
  Dissertationes Universitatis Helsingiensis 2024
  +Save
• Combining fibril‐induced alpha‐synuclein aggregation and 6‐hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration
  European Journal of Neuroscience 2023 DOI: 10.1111/ejn.16196
  +Save
• Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration
  Neuroscience Letters 2023 DOI: 10.1016/j.neulet.2023.137510
  +Save
• Cerebral Dopamine Neurotrophic Factor Reduces α-Synuclein Aggregation and Propagation and Alleviates Behavioural Alterations in vivo
  Molecular Therapy 2021 DOI: 10.1016/j.ymthe.2021.04.035
  +Save
• Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease – A Focused Review
  Current Gene Therapy 2016 DOI: 10.2174/1566523216666160729113558
  +Save
• Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015)
  Stem Cell Research & Therapy 2016 DOI: 10.1186/s13287-016-0341-0
  +Save